KEGG   PATHWAY: ko04380
Entry
ko04380                     Pathway                                
Name
Osteoclast differentiation
Description
The osteoclasts, multinucleared cells originating from the hematopoietic monocyte-macrophage lineage, are responsible for bone resorption. Osteoclastogenesis is mainly regulated by signaling pathways activated by RANK and immune receptors, whose ligands are expressed on the surface of osteoblasts. Signaling from RANK changes gene expression patterns through transcription factors like NFATc1 and characterizes the active osteoclast.
Class
Organismal Systems; Development and regeneration
Pathway map
ko04380  Osteoclast differentiation
ko04380

Other DBs
GO: 0030316
Orthology
K00922  PIK3CA_B_D; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta [EC:2.7.1.153]
K01371  CTSK; cathepsin K [EC:3.4.22.38]
K02580  NFKB1; nuclear factor NF-kappa-B p105 subunit
K02649  PIK3R1_2_3; phosphoinositide-3-kinase regulatory subunit alpha/beta/delta
K03156  TNF, TNFA; tumor necrosis factor superfamily, member 2
K03158  TNFRSF1A, TNFR1, CD120a; tumor necrosis factor receptor superfamily member 1A
K03173  TRAF2; TNF receptor-associated factor 2 [EC:2.3.2.27]
K03175  TRAF6; TNF receptor-associated factor 6 [EC:2.3.2.27]
K04348  PPP3C, CNA; serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16]
K04364  GRB2; growth factor receptor-bound protein 2
K04368  MAP2K1, MEK1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
K04371  ERK, MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04379  FOS; proto-oncogene protein c-fos
K04383  IL1A; interleukin 1 alpha
K04386  IL1R1, CD121a; interleukin 1 receptor type I
K04388  TGFBR2; TGF-beta receptor type-2 [EC:2.7.11.30]
K04392  RAC1; Ras-related C3 botulinum toxin substrate 1
K04403  MAP3K7IP1, TAB1; TAK1-binding protein 1
K04404  MAP3K7IP2, TAB2; TAK1-binding protein 2
K04427  MAP3K7, TAK1; mitogen-activated protein kinase kinase kinase 7 [EC:2.7.11.25]
K04431  MAP2K7, MKK7; mitogen-activated protein kinase kinase 7 [EC:2.7.12.2]
K04433  MAP2K6, MKK6; mitogen-activated protein kinase kinase 6 [EC:2.7.12.2]
K04440  JNK; mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:2.7.11.24]
K04441  P38; p38 MAP kinase [EC:2.7.11.24]
K04446  NFATC1, NFAT2, NFATC; nuclear factor of activated T-cells, cytoplasmic 1
K04448  JUN; transcription factor AP-1
K04449  JUND; transcription factor jun-D
K04456  AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04466  MAP3K14, NIK; mitogen-activated protein kinase kinase kinase 14 [EC:2.7.11.25]
K04467  IKBKA, IKKA, CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10]
K04469  NFKB2; nuclear factor of kappa light polypeptide gene enhancer in B-cells 2
K04502  FOSL1; fos-like antigen 1
K04519  IL1B; interleukin 1 beta
K04576  CALCR; calcitonin receptor
K04674  TGFBR1, ALK5; TGF-beta receptor type-1 [EC:2.7.11.30]
K04687  IFNG; interferon gamma
K04693  IRF9, ISGF3G, P48; interferon regulatory factor 9
K04694  SOCS1, JAB; suppressor of cytokine signaling 1
K04696  SOCS3, CIS3; suppressor of cytokine signaling 3
K04734  NFKBIA; NF-kappa-B inhibitor alpha
K04735  RELA; transcription factor p65
K04958  ITPR1; inositol 1,4,5-triphosphate receptor type 1
K04959  ITPR2; inositol 1,4,5-triphosphate receptor type 2
K04960  ITPR3; inositol 1,4,5-triphosphate receptor type 3
K05090  CSF1R, FMS, CD115; macrophage colony-stimulating factor 1 receptor [EC:2.7.10.1]
K05130  IFNAR1; interferon receptor 1
K05131  IFNAR2; interferon receptor 2
K05132  IFNGR1, CD119; interferon gamma receptor 1
K05133  IFNGR2; interferon gamma receptor 2
K05147  TNFRSF11A, RANK, CD265; tumor necrosis factor receptor superfamily member 11A
K05148  TNFRSF11B, OPG; tumor necrosis factor receptor superfamily member 11B
K05415  IFNB; interferon beta
K05453  CSF1, MCSF; macrophage colony-stimulating factor 1
K05473  TNFSF11, RANKL, CD254; tumor necrosis factor ligand superfamily member 11
K05703  FYN; tyrosine-protein kinase Fyn [EC:2.7.10.2]
K05853  ATP2A; P-type Ca2+ transporter type 2A [EC:7.2.2.10]
K05855  SYK; spleen tyrosine kinase [EC:2.7.10.2]
K05856  LCK; lymphocyte cell-specific protein tyrosine kinase [EC:2.7.10.2]
K05859  PLCG2; phosphatidylinositol phospholipase C, gamma-2 [EC:3.1.4.11]
K05869  CAMK4; calcium/calmodulin-dependent protein kinase IV [EC:2.7.11.17]
K05870  CREB1; cyclic AMP-responsive element-binding protein 1
K06268  PPP3R, CNB; serine/threonine-protein phosphatase 2B regulatory subunit
K06463  FCGR3, CD16; low affinity immunoglobulin gamma Fc receptor III
K06472  FCGR2A, CD32; low affinity immunoglobulin gamma Fc receptor II-a
K06493  ITGB3, CD61; integrin beta 3
K06498  FCGR1A, CD64; high affinity immunoglobulin gamma Fc receptor I
K06512  LILR, CD85; leukocyte immunoglobulin-like receptor
K06551  SIRPA_B1_G, CD172; signal-regulatory protein alpha/beta1/gamma
K07209  IKBKB, IKKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
K07210  IKBKG, IKKG, NEMO; inhibitor of nuclear factor kappa-B kinase subunit gamma
K07361  LCP2; lymphocyte cytosolic protein 2
K07364  TEC; tyrosine-protein kinase Tec [EC:2.7.10.2]
K07370  BTK; Bruton agammaglobulinemia tyrosine kinase [EC:2.7.10.2]
K07371  BLNK; B-cell linker protein
K07992  TYROBP, DAP12; TYRO protein tyrosine kinase binding protein
K08008  NOX1, MOX1; NADPH oxidase 1
K08009  CYBA, P22PHOX; cytochrome b-245, alpha polypeptide
K08010  NCF2, P67PHOX; neutrophil cytosolic factor 2
K08011  NCF1, P47PHOX; neutrophil cytosolic factor 1
K08012  NCF4, P40PHOX; neutrophil cytosolic factor 4
K08091  GAB2; GRB2-associated-binding protein 2
K08530  NR1C3, PPARG; peroxisome proliferator-activated receptor gamma
K08601  CYLD, USLP2; ubiquitin carboxyl-terminal hydrolase CYLD [EC:3.4.19.12]
K09028  JUNB; transcription factor jun-B
K09029  FOSB; protein FosB
K09030  FOSL2; fos-like antigen 2
K09253  RELB; transcription factor RelB
K09438  SPI1; transcription factor PU.1
K09455  MITF; microphthalmia-associated transcription factor
K11217  JAK1; Janus kinase 1 [EC:2.7.10.2]
K11219  TYK2; non-receptor tyrosine-protein kinase TYK2 [EC:2.7.10.2]
K11220  STAT1; signal transducer and activator of transcription 1
K11221  STAT2; signal transducer and activator of transcription 2
K12560  FCGR2B, CD32; low affinity immunoglobulin gamma Fc receptor II-b
K13375  TGFB1; transforming growth factor beta-1
K13376  TGFB2; transforming growth factor beta-2
K14377  OSCAR; osteoclast-associated immunoglobulin-like receptor
K14378  TREM2; triggering receptor expressed on myeloid cells 2
K14379  ACP5; tartrate-resistant acid phosphatase type 5 [EC:3.1.3.2]
K14380  FHL2; four and a half LIM domains protein 2
K14381  SQSTM1; sequestosome 1
K16824  FCGR2C, CD32; low affinity immunoglobulin gamma Fc receptor II-c
K17332  NFATC2, NFAT1, NFATP; nuclear factor of activated T-cells, cytoplasmic 2
K26770  TMEM64; transmembrane protein 64
Compound
C00027  Hydrogen peroxide
C00076  Calcium cation
C01245  D-myo-Inositol 1,4,5-trisphosphate
Reference
  Authors
Takayanagi H, Sato K, Takaoka A, Taniguchi T
  Title
Interplay between interferon and other cytokine systems in bone metabolism.
  Journal
Immunol Rev 208:181-93 (2005)
DOI:10.1111/j.0105-2896.2005.00337.x
Reference
  Authors
Takayanagi H
  Title
New immune connections in osteoclast formation.
  Journal
Ann N Y Acad Sci 1192:117-23 (2010)
DOI:10.1111/j.1749-6632.2009.05303.x
Reference
  Authors
Nakashima T, Takayanagi H
  Title
Osteoimmunology: crosstalk between the immune and bone systems.
  Journal
J Clin Immunol 29:555-67 (2009)
DOI:10.1007/s10875-009-9316-6
Reference
  Authors
Caetano-Lopes J, Canhao H, Fonseca JE
  Title
Osteoimmunology--the hidden immune regulation of bone.
  Journal
Autoimmun Rev 8:250-5 (2009)
DOI:10.1016/j.autrev.2008.07.038
Reference
  Authors
Lorenzo J, Horowitz M, Choi Y
  Title
Osteoimmunology: interactions of the bone and immune system.
  Journal
Endocr Rev 29:403-40 (2008)
DOI:10.1210/er.2007-0038
Reference
  Authors
David JP
  Title
Osteoimmunology: a view from the bone.
  Journal
Adv Immunol 95:149-65 (2007)
DOI:10.1016/S0065-2776(07)95005-1
Reference
  Authors
Jimi E, Ghosh S
  Title
Role of nuclear factor-kappaB in the immune system and bone.
  Journal
Immunol Rev 208:80-7 (2005)
DOI:10.1111/j.0105-2896.2005.00329.x
Reference
  Authors
Boyle WJ, Simonet WS, Lacey DL
  Title
Osteoclast differentiation and activation.
  Journal
Nature 423:337-42 (2003)
DOI:10.1038/nature01658
Reference
  Authors
Darnay BG, Besse A, Poblenz AT, Lamothe B, Jacoby JJ
  Title
TRAFs in RANK signaling.
  Journal
Adv Exp Med Biol 597:152-9 (2007)
DOI:10.1007/978-0-387-70630-6_12
Reference
  Authors
Baron R
  Title
Arming the osteoclast.
  Journal
Nat Med 10:458-60 (2004)
DOI:10.1038/nm0504-458
Reference
  Authors
Takayanagi H
  Title
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems.
  Journal
Nat Rev Immunol 7:292-304 (2007)
DOI:10.1038/nri2062
Reference
  Authors
Krum SA, Chang J, Miranda-Carboni G, Wang CY
  Title
Novel functions for NFkappaB: inhibition of bone formation.
  Journal
Nat Rev Rheumatol 6:607-11 (2010)
DOI:10.1038/nrrheum.2010.133
Reference
  Authors
Lee NK, Choi YG, Baik JY, Han SY, Jeong DW, Bae YS, Kim N, Lee SY
  Title
A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation.
  Journal
Blood 106:852-9 (2005)
DOI:10.1182/blood-2004-09-3662
Reference
  Authors
Shinohara M, Koga T, Okamoto K, Sakaguchi S, Arai K, Yasuda H, Takai T, Kodama T, Morio T, Geha RS, Kitamura D, Kurosaki T, Ellmeier W, Takayanagi H
  Title
Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals.
  Journal
Cell 132:794-806 (2008)
DOI:10.1016/j.cell.2007.12.037
Reference
  Authors
Takayanagi H, Kim S, Koga T, Taniguchi T
  Title
Stat1-mediated cytoplasmic attenuation in osteoimmunology.
  Journal
J Cell Biochem 94:232-40 (2005)
DOI:10.1002/jcb.20316
Reference
  Authors
Jin W, Chang M, Paul EM, Babu G, Lee AJ, Reiley W, Wright A, Zhang M, You J, Sun SC
  Title
Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice.
  Journal
J Clin Invest 118:1858-66 (2008)
DOI:10.1172/JCI34257
Reference
  Authors
Bai S, Kitaura H, Zhao H, Chen J, Muller JM, Schule R, Darnay B, Novack DV, Ross FP, Teitelbaum SL
  Title
FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner.
  Journal
J Clin Invest 115:2742-51 (2005)
DOI:10.1172/JCI24921
Reference
  Authors
Takayanagi H, Kim S, Taniguchi T
  Title
Signaling crosstalk between RANKL and interferons in osteoclast differentiation.
  Journal
Arthritis Res 4 Suppl 3:S227-32 (2002)
DOI:10.1186/ar581
Related
pathway
ko04010  MAPK signaling pathway
ko04020  Calcium signaling pathway
ko04064  NF-kappa B signaling pathway
ko04151  PI3K-Akt signaling pathway
ko04630  JAK-STAT signaling pathway

DBGET integrated database retrieval system